Hemostasis & Tissue Sealing Agents Market to amass US $3990 Mn by 2024

September 25, 2019


According to the latest study titled ‘Global Hemostasis and Tissue Sealing Agents Market Growth 2019-2024’ available with Market Study Report LLC, global hemostasis and tissue sealing agents market is predicted to accumulate US $3990 million by the year 2024.
 

Hemostasis is a process that stops bleeding and helps to keep blood within the damaged blood vessel. This is the initial stage of wound healing. During medical procedures tissue sealing agents are used to achieve hemostasis. These agents differ based on the composition, mechanism of action, ease of application, immunogenicity, adherence to tissue, and cost.
 

The tissue sealing agents allow better visualization of surgical area, rapid hemostasis, short span of operations, reduce wound healing time, decrease requirement for transfusions and overall improvement in patient recovery time, thereby propelling the growth of hemostasis & tissue sealing agents market.
 

According to the study, the global hemostasis and tissue sealing agents market was valued at US $2810 million in 2019 and is estimated to increase with a CAGR of 6.0% over the projected timeline. Moreover, the study analyzes the market on various parameters including market share and growth opportunities across several segments.  
 

Based on product type, the industry is segmented as tissue sealing agents and hemostasis agents, wherein the later segment held 64% share in 20417. While, on the basis of application spectrum, the global hemostasis and tissue sealing agents market is divided as general surgery, minimally invasive surgery, and other.     
 

Request sample copy of this Reporthttps://www.marketstudyreport.com/request-a-sample/1628605/
 

While considering the geographical landscape, hemostasis & tissue sealing agents market is fragmented into four major regions as Europe, Americas, Middle East & Africa, and Asia Pacific. Furthermore, North America dominated the product market with 42% consumption share in 2017, cites the report.
 

Some of the vendors that operate in the global hemostasis and tissue sealing agents market outlined in the report comprise of Baxter, Johnson & Johnson, C R Bard, Integra Life Sciences, Gelita, Advance Medical Solution, CSL Behring, Pfizer, Zimmer Biomet, CryoLife, Ferrosan Medical Devices, Smith & Nephew, Medtronic, Equimedical, Marine Polymer, Z-Medica, and B Braun.